| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.33 | 2e-24 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.18 | 8e-08 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |